What is the recommended treatment for a vaginal herpes simplex infection?

Treatment of Vaginal Herpes Simplex Infection

For a first clinical episode of genital herpes, treat with oral acyclovir 200 mg five times daily for 7-10 days until clinical resolution, or alternatively valacyclovir 1000 mg twice daily for the same duration. 1

First Clinical Episode (Primary Infection)

The initial presentation requires the most aggressive treatment approach because symptoms are typically more severe and prolonged:

• Acyclovir 200 mg orally 5 times daily for 7-10 days (continue until clinical resolution) 1
• Alternative: Valacyclovir 1000 mg orally twice daily for 5-10 days 2, 3
• Alternative: Famciclovir (though less studied, comparable efficacy to acyclovir) 1

Critical caveat: Topical acyclovir is substantially less effective than oral therapy and should be avoided 1. Systemic therapy provides partial control of symptoms but does not eradicate latent virus or prevent future recurrences 1.

Recurrent Episodes

For immunocompetent patients with recurrent genital herpes, treatment benefit is limited unless started during prodrome or within 1-2 days of lesion onset 1:

Episodic therapy options (choose one):

• Acyclovir 400 mg orally 3 times daily for 5 days 1
• Acyclovir 800 mg orally twice daily for 5 days 1
• Valacyclovir 500 mg orally twice daily for 5 days 1
• Famciclovir 125 mg orally twice daily for 5 days 1

Important consideration: Most immunocompetent patients with recurrent disease do not benefit significantly from episodic treatment because early administration is rarely feasible 1.

Suppressive Therapy

Daily suppressive therapy reduces HSV recurrence frequency by ≥75% in patients with frequent recurrences (≥6 episodes per year) 1:

Recommended regimens (choose one):

• Acyclovir 400 mg orally twice daily 1
• Valacyclovir 500 mg orally once daily (less effective if ≥10 recurrences/year) 1
• Valacyclovir 1000 mg orally once daily 1
• Famciclovir 250 mg orally twice daily 1

Key management points:

• Safety and efficacy documented for acyclovir use up to 5-6 years 1
• After 1 year of continuous therapy, discontinue to reassess recurrence rate 1
• Suppressive therapy reduces but does not eliminate asymptomatic viral shedding and transmission risk 1
• Acyclovir-resistant strains rarely cause treatment failure in immunocompetent patients 1

Severe Disease Requiring Hospitalization

For extensive disease, disseminated infection, or complications (encephalitis, pneumonitis, hepatitis):

Acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical resolution 1

Special Populations

HIV-Infected/Immunocompromised Patients

• Require more aggressive therapy with prolonged or severe episodes 1
• Acyclovir 400 mg orally 3-5 times daily until clinical resolution 1
• Famciclovir 500 mg twice daily effective for reducing recurrences and subclinical shedding 1
• Warning: Valacyclovir doses of 8 g/day associated with hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in immunocompromised patients; standard doses appear safe 1
• Consider acyclovir-resistant strains if lesions persist despite treatment 1

Pregnancy

• First episode or recurrence during pregnancy: Acyclovir 200 mg 5 times daily or valacyclovir 500-1000 mg twice daily for 5-10 days 2, 3
• Prophylactic suppression from 36 weeks gestation until delivery: Acyclovir 400 mg three times daily or valacyclovir 500 mg twice daily 2, 3
• Cesarean delivery recommended if active lesions present at labor onset or first episode occurred <6 weeks before delivery 3

Essential Counseling Points

All patients must receive comprehensive education 1:

• Abstain from sexual activity when lesions or prodromal symptoms present 1
• Use condoms during all sexual exposures (transmission can occur during asymptomatic periods) 1
• Asymptomatic viral shedding occurs more frequently with HSV-2 than HSV-1 and during first 12 months of infection 1
• Women of childbearing age must inform obstetric providers about HSV infection due to neonatal transmission risk 1
• Sex partners require evaluation and counseling even if asymptomatic 1

Treatment Selection Algorithm

Choose based on clinical scenario:

1. First episode with symptoms → Acyclovir 200 mg 5x/day for 7-10 days
2. Recurrent episode, early presentation → Acyclovir 800 mg twice daily for 5 days
3. Frequent recurrences (≥6/year) → Suppressive therapy with acyclovir 400 mg twice daily
4. Severe disease/hospitalization → IV acyclovir 5-10 mg/kg every 8 hours
5. Immunocompromised → Higher doses (acyclovir 400 mg 3-5x/day) with longer duration

Common pitfall: Starting episodic therapy too late in recurrent episodes provides minimal benefit; patients should have medication available to start at first prodromal symptom 1.